Tags

Type your tag names separated by a space and hit enter

Contraceptive choices in women with coagulation disorders.
Am J Obstet Gynecol. 1993 Jun; 168(6 Pt 2):1990-3.AJ

Abstract

When compared with older reports on the thromboembolic effects of high-dose oral contraceptives, new studies with low-dose oral contraceptives have a significantly reduced risk of thromboembolism. In the absence of risk factors such as smoking or inherited disorders predisposing to thrombosis, the modern low-dose oral contraceptive (< 50 micrograms of estrogen) is a safe and effective choice for contraception in women without symptoms who have family histories of sporadic thromboembolism. An intrauterine device or some form of barrier method is recommended for women who have a personal history of venous thrombus disease. The low-dose oral contraceptive may be a good choice in women taking oral anticoagulants because of the risk of teratogenic effects of anticoagulants and the risks of intraperitoneal bleeding associated with ovulation. In addition, oral contraceptives help diminish the excessive menstrual bleeding often seen in these women.

Authors+Show Affiliations

Department of Medicine, University of Oklahoma Health Sciences Center.No affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

8512043

Citation

Comp, P C., and H A. Zacur. "Contraceptive Choices in Women With Coagulation Disorders." American Journal of Obstetrics and Gynecology, vol. 168, no. 6 Pt 2, 1993, pp. 1990-3.
Comp PC, Zacur HA. Contraceptive choices in women with coagulation disorders. Am J Obstet Gynecol. 1993;168(6 Pt 2):1990-3.
Comp, P. C., & Zacur, H. A. (1993). Contraceptive choices in women with coagulation disorders. American Journal of Obstetrics and Gynecology, 168(6 Pt 2), 1990-3.
Comp PC, Zacur HA. Contraceptive Choices in Women With Coagulation Disorders. Am J Obstet Gynecol. 1993;168(6 Pt 2):1990-3. PubMed PMID: 8512043.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Contraceptive choices in women with coagulation disorders. AU - Comp,P C, AU - Zacur,H A, PY - 1993/6/1/pubmed PY - 1993/6/1/medline PY - 1993/6/1/entrez KW - Antibodies KW - Biology KW - Blood Coagulation Effects--women KW - Contraception KW - Contraceptive Methods--contraindications KW - Contraceptive Methods--side effects KW - Diseases KW - Drugs KW - Embolism KW - Endocrine System KW - Estrogens KW - Family Planning KW - Heart Diseases--women KW - Hematological Effects KW - Hemic System KW - Hormones KW - Immunity KW - Immunologic Factors KW - Literature Review KW - Oral Contraceptives, Low-dose KW - Oral Contraceptives--contraindications KW - Oral Contraceptives--side effects KW - Physiology KW - Progestational Hormones KW - Progesterone KW - Pulmonary Embolism KW - Recommendations KW - Surgery KW - Thromboembolism--women KW - Thrombosis--etiology KW - Treatment KW - Vascular Diseases SP - 1990 EP - 3 JF - American journal of obstetrics and gynecology JO - Am. J. Obstet. Gynecol. VL - 168 IS - 6 Pt 2 N2 - When compared with older reports on the thromboembolic effects of high-dose oral contraceptives, new studies with low-dose oral contraceptives have a significantly reduced risk of thromboembolism. In the absence of risk factors such as smoking or inherited disorders predisposing to thrombosis, the modern low-dose oral contraceptive (< 50 micrograms of estrogen) is a safe and effective choice for contraception in women without symptoms who have family histories of sporadic thromboembolism. An intrauterine device or some form of barrier method is recommended for women who have a personal history of venous thrombus disease. The low-dose oral contraceptive may be a good choice in women taking oral anticoagulants because of the risk of teratogenic effects of anticoagulants and the risks of intraperitoneal bleeding associated with ovulation. In addition, oral contraceptives help diminish the excessive menstrual bleeding often seen in these women. SN - 0002-9378 UR - https://www.unboundmedicine.com/medline/citation/8512043/Contraceptive_choices_in_women_with_coagulation_disorders_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0002-9378(12)90940-0 DB - PRIME DP - Unbound Medicine ER -